A number of obstacles can stand in the way of Black women receiving timely breast cancer treatment, including lack of insurance, transportation access and financial strain, reports STAT.
The Latest
The COVID-19 pandemic has had a profound impact on cancer screenings and treatments, and researchers are now warning that delaying cancer treatment by just one month can lead to a 6 percent to 13 percent higher death risk, according to…
Using proton therapy to treat lung cancer patients was linked to a reduction in ministrokes and heart attacks compared to patients who received traditional photon-based therapy, according to new research from Philadelphia-based Penn Medicine.
Reno, Nev.-based Renown Health debuted a new cancer center leadership team Oct. 29 with the appointment of Max Coppes, MD, PhD, as the cancer center director for Renown's Institute for Cancer, and Larry Duncan as the cancer center administrator, according…
Genetic testing identifies inherited cancer mutations more effectively than a standard guideline-based approach, according to research published in JAMA Oncology.
The U.S. Department of Defense Breast Cancer Research Program awarded Erik Nelson, PhD, the $4.5 million Era of Hope Scholar Award Oct. 30 to lead a research team that will study metastatic breast cancer treatment and prevention.
The Herbert Irving Comprehensive Cancer Center at Columbia University and NewYork-Presbyterian appointed Adam Bass, MD, founding director of the Center for Precision Cancer Medicine.
Since the July 2016 Medicaid expansion in Louisiana, there's been a 27 percent increase in early diagnosis of breast cancer, according to an upcoming study set for publication in Cancer.
Private equity buying sprees in radiation oncology along Florida's Paradise Coast have some physicians, researchers and antitrust regulators concerned, according to Bloomberg.
Cancer patients with COVID-19 have a 12.5 percent higher death risk compared to non-cancer patients with the illness, according to a study published today in Cancer.